Sphingosine kinase and sphingosine-1-phosphate receptor signaling pathway in inflammatory gastrointestinal disease and cancers: A novel therapeutic target

OA Sukocheva, H Furuya, ML Ng, M Friedemann… - Pharmacology & …, 2020 - Elsevier
Inflammatory gastrointestinal (GI) diseases and malignancies are associated with growing
morbidity and cancer-related mortality worldwide. GI tumor and inflammatory cells contain …

Tumor microenvironment: key players in triple negative breast cancer immunomodulation

H Zheng, S Siddharth, S Parida, X Wu, D Sharma - Cancers, 2021 - mdpi.com
Simple Summary The tumor microenvironment (TME) is a complicated network composed of
various cells, signaling molecules, and extra cellular matrix. TME plays a crucial role in triple …

Bone marrow mesenchymal stem cells‐derived exosomes reduce Aβ deposition and improve cognitive function recovery in mice with Alzheimer's disease by …

X Wang, G Yang - Cell biology international, 2021 - Wiley Online Library
Exosomes are associated with the development and progression of Alzheimer's disease
(AD), although the impact of these extracellular vesicles in brain pathological condition …

Atractylenolide-1 targets SPHK1 and B4GALT2 to regulate intestinal metabolism and flora composition to improve inflammation in mice with colitis

L Qu, K Shi, J Xu, C Liu, C Ke, X Zhan, K Xu, Y Liu - Phytomedicine, 2022 - Elsevier
Background Atractylenolide-1, an active component of Atractylodes Lancea, which is widely
used to improve the gastrointestinal function. However, the efficacy and mechanism remain …

The emerging roles of sphingosine 1-phosphate and SphK1 in cancer resistance: a promising therapeutic target

SS Alkafaas, MI Elsalahaty, DF Ismail… - Cancer Cell …, 2024 - Springer
Cancer chemoresistance is a problematic dilemma that significantly restrains numerous
cancer management protocols. It can promote cancer recurrence, spreading of cancer, and …

Sphingosine 1‐phosphate lyase facilitates cancer progression through converting sphingolipids to glycerophospholipids

B Uranbileg, M Kurano, K Kano, E Sakai… - Clinical and …, 2022 - Wiley Online Library
Background In addition to potent agonist properties for sphingosine 1‐phosphate (S1P)
receptors, intracellularly, S1P is an intermediate in metabolic conversion pathway from …

Evaluation of binding and inhibition mechanism of dietary phytochemicals with sphingosine kinase 1: Towards targeted anticancer therapy

P Gupta, T Mohammad, R Dahiya, S Roy… - Scientific Reports, 2019 - nature.com
Abstract Sphingosine kinase 1 (SphK1) has recently gained attention as a potential drug
target for its association with cancer and other inflammatory diseases. Here, we have …

Consequences of EMT-driven changes in the immune microenvironment of breast cancer and therapeutic response of cancer cells

S Singh, R Chakrabarti - Journal of clinical medicine, 2019 - mdpi.com
Epithelial-to-mesenchymal transition (EMT) is a process through which epithelial cells lose
their epithelial characteristics and cell–cell contact, thus increasing their invasive potential …

Sphingolipids as mediators of inflammation and novel therapeutic target in inflammatory bowel disease

OA Sukocheva, E Lukina, E McGowan… - Advances in protein …, 2020 - Elsevier
Morbidity of inflammatory gastrointestinal (GI) diseases continues to grow resulting in
worsen quality of life and increased burden on public medical systems. Complex and …

[HTML][HTML] Conjugated bile acids promote invasive growth of esophageal adenocarcinoma cells and cancer stem cell expansion via sphingosine 1-phosphate receptor 2 …

R Liu, X Li, PB Hylemon, H Zhou - The American journal of pathology, 2018 - Elsevier
Esophageal adenocarcinoma (EAC) is the sixth leading cause of cancer deaths worldwide
and has been dramatically increasing in incidence over the past decade. Gastroesophageal …